Novel selective serotonin reuptake inhibitors, Part I.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D015994:Incidence; D014179:Neurotransmitter Uptake Inhibitors / Q000627:therapeutic use*; D017374:Paroxetine; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced / Q000453:epidemiology; D012701:Serotonin / Q000502:physiology*; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data
D000929:Antidepressive Agents, Tricyclic; D014179:Neurotransmitter Uptake Inhibitors; D010880:Piperidines; D012701:Serotonin; D017374:Paroxetine